WASHINGTON, Jan. 8 -- The U.S. Department of Health and Human Services' Food and Drug Administration announced that it expects to award a cooperative agreement for the development of advanced analytical methods for the analysis of complex drug product iron carbohydrate complex-ferric derisomaltose. The agency description of the cooperative agreement states: "Development of advanced analytical methods for the characterization and comparative analysis of complex products are important for linking more ST

WASHINGTON, Jan. 8 -- The U.S. Department of Health and Human Services' Food and Drug Administration announced that it expects to award up to two cooperative agreements for physiologically based pharmacokinetic models of oral absorption to simulate the results of bioequivalence studies. The agency description of the cooperative agreement states: "Physiologically based pharmacokinetic (PBPK) models are an effective tool to integrate information about the product characteristics, the physiology o more ST

WASHINGTON, Jan. 8 -- The U.S. Department of Health and Human Services' Food and Drug Administration announced that it expects to award up to five cooperative agreements for research to quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans. The agency description of the cooperative agreement states: "The purpose of this funding opportunity is to systematically quantify the protein levels of potential metabolizi more ST